Pregnancy with Congenital Heart Disease: Risks, Planning, and Care

Pregnancy changes everything about how your heart works. Blood volume increases by 30 to 50%. Cardiac output rises. Heart rate goes up. The demands on your circulatory system during those nine months — and in the hours around delivery — are unlike anything your heart experiences at any other time in your life.

A structurally normal heart handles this reliably. A congenital heart may not.

The heart that was built differently, repaired in childhood, or managed carefully for years now faces a physiologic stress test it wasn't designed for. That doesn't mean pregnancy is off the table — most women with CHD can have safe pregnancies. But it requires planning, the right team, and honest risk assessment before conception, not during it.

The information below is not a substitute for individualized counseling with your cardiologist and maternal-fetal medicine specialist.

Why Cardiac Disease Is the Leading Non-Obstetric Cause of Maternal Death

Cardiovascular disease now accounts for more maternal deaths in the United States than any other non-obstetric cause. A significant portion of those deaths involve women with congenital heart disease — including conditions that were well-managed and seemingly stable.

The reason isn't that CHD always makes pregnancy dangerous. It's that the risk is frequently underestimated, the right specialists aren't always involved, and the warning signs aren't always recognized in time.

Women with CHD deserve an honest account of what pregnancy will ask of their heart — not false reassurance, and not catastrophizing. The goal is informed decision-making based on your specific anatomy, not a generic conversation about "heart conditions."

Risk Is Not One-Size-Fits-All

The first thing to understand is that "congenital heart disease" covers an enormous range of conditions. The cardiac risks of pregnancy in a woman with a small, repaired atrial septal defect and normal ventricular function are fundamentally different from the risks in a woman with Fontan circulation, pulmonary arterial hypertension, or a systemic right ventricle.

Risk stratification is a core part of cardio-obstetric care. The modified WHO (mWHO) classification system is the standard framework. It classifies cardiac conditions into four risk categories, from Class I (no detectable increased risk) to Class IV (conditions where pregnancy is contraindicated because the risk of death or severe morbidity is unacceptably high).

Conditions typically classified as high-risk or very high-risk include:

• Pulmonary arterial hypertension (including Eisenmenger syndrome) — historically carries maternal mortality rates of 20-50%, and remains a Class IV designation
• Fontan circulation — not an absolute contraindication, but requires intensive management; outcomes depend heavily on Fontan function and hepatic status
• Severe systemic ventricular dysfunction (ejection fraction below 30%)
• Severe left-sided obstruction — severe aortic stenosis, severe mitral stenosis
• Significant aortopathy — aortic root dilation in conditions like Marfan syndrome or bicuspid aortic valve-associated aortopathy

Conditions typically classified as moderate risk include:

• Repaired Tetralogy of Fallot — generally manageable with appropriate surveillance, but right ventricular function and pulmonary valve status matter significantly
• Mechanical prosthetic valves — anticoagulation management during pregnancy is one of the most complex aspects of cardiac obstetrics
• Coarctation of the aorta — repaired and unrepaired, with attention to blood pressure control
• Systemic right ventricle — patients with d-TGA after atrial switch operations

This is not an exhaustive list. The point is that your risk level is specific to your anatomy — and that assessment has to come from a specialist who knows your cardiac history in detail.

Pre-Pregnancy Planning Is the Most Important Step

The single most impactful intervention in managing pregnancy with CHD is the conversation that happens before conception.

By the time a woman with congenital heart disease is presenting to an obstetrician with a positive pregnancy test, the window for some of the most important decisions has already closed. Medication changes that would have been ideal to make in advance now carry fetal exposure concerns. Cardiac interventions that might have reduced risk — a valve repair, a Fontan revision, an ablation for arrhythmia — are no longer straightforward to pursue.

Pre-pregnancy counseling with an ACHD specialist and a maternal-fetal medicine physician (MFM) should happen at least six to twelve months before planned conception for any woman with moderate or high-risk CHD. That consultation should include:

• A full cardiac evaluation — echocardiogram, functional assessment, rhythm monitoring as indicated
• Risk stratification using the mWHO classification
• Review of current medications for fetal safety (ACE inhibitors, ARBs, warfarin, and others carry significant teratogenic risk)
• Discussion of delivery planning — which hospital, which team, whether delivery in a cardiac surgery-capable center is necessary
• Honest conversation about whether pregnancy should be pursued, deferred, or reconsidered

For women in the higher risk categories, this conversation may include a frank discussion about contraception. Not all contraceptive options are safe for women with certain CHD diagnoses — estrogen-containing methods carry thrombotic risk that is unacceptable in some conditions, and the IUD insertion process carries procedural risks in others. Contraceptive planning is cardiac care.

During Pregnancy: What Monitoring Looks Like

The intensity of cardiac monitoring during pregnancy depends entirely on risk classification. Women with Class I or II conditions may be followed every trimester with standard obstetric care and periodic cardiology review. Women with Class III or IV conditions require multidisciplinary management throughout pregnancy, often with monthly or more frequent cardiac assessments.

Key elements of cardiac monitoring during pregnancy include:

Echocardiography. Repeat echocardiograms are typically performed at least once per trimester for moderate and high-risk patients. More frequent imaging may be required if cardiac function is changing.

Arrhythmia monitoring. Pregnancy increases arrhythmia susceptibility. For patients with prior history of arrhythmia or rhythm-sensitive anatomy, closer monitoring is appropriate.

Blood pressure management. Hypertensive disorders of pregnancy are more common in women with CHD. Safe antihypertensive options in pregnancy differ from standard cardiac management — labetalol, nifedipine, and methyldopa are the workhorses; ACE inhibitors and ARBs are contraindicated.

Anticoagulation. Women with mechanical prosthetic valves or Fontan circulation with certain indications require anticoagulation throughout pregnancy. Managing that anticoagulation — balancing maternal and fetal risk — demands a specialist. There is no adequate general cardiology approach here.

Delivery planning. The mode, timing, and setting of delivery are cardiac decisions as much as obstetric ones. For many high-risk patients, planned delivery in a hospital with on-site cardiac surgery capability is essential. The anesthetic plan matters — epidural analgesia is often preferable for its hemodynamic effects. The immediate postpartum period, when blood redistribution causes significant hemodynamic shifts, is a high-risk window that requires close monitoring.

The Postpartum Period Is Not the Finish Line

Maternal cardiac mortality peaks not during delivery but in the weeks that follow.

The postpartum period brings abrupt hemodynamic shifts as fluid redistributes from the extravascular space into the circulation. For women with limited cardiac reserve, this volume load can precipitate decompensation. Postpartum hemorrhage, infection, and thrombotic risk are all elevated. Sleep deprivation and the physiologic demands of newborn care compound everything.

Close postpartum cardiac follow-up — not just a six-week OB check — is essential for women with moderate or high-risk CHD. Most practices don't have a postpartum cardiac protocol. Most patients don't know to ask for one.

What Cardio-Obstetrics Actually Means

Cardio-obstetrics is the subspecialty at the intersection of cardiology and obstetrics. It requires both disciplines — a cardiologist who understands pregnancy physiology and an obstetrician who understands cardiac disease. In practice, the most effective care involves an ACHD specialist, a maternal-fetal medicine physician, a cardiac anesthesiologist, and — at high-risk centers — cardiac surgery availability.

This level of coordination doesn't happen automatically. Someone has to build it and maintain it. The cardiologist who knows your anatomy and the MFM managing your pregnancy need to be talking to each other, not just leaving notes in the same chart.

At Congenital Heart Compass, we build those care relationships intentionally. For patients in Rochester and the Western New York region, our goal is to ensure you have the right team around you before the first positive test — and that the coordination across that team continues throughout.

The Conversation Every Woman with CHD Deserves

Pregnancy with congenital heart disease is not a simple topic, and it doesn't get simpler by avoiding it.

If you have CHD and are considering pregnancy — or if you're a patient of childbearing age who hasn't had this conversation with a specialist — now is the time. Not because pregnancy is necessarily dangerous for you, but because the difference between a managed risk and an unmanaged one is often just the quality of the planning that happened before.

Schedule a pre-pregnancy consultation or ask your cardiologist for a referral to our practice. The earlier this conversation happens, the more options exist — including ones that close after conception.

Dr. Pradeepkumar Charla, MD, MBA specializes in adult congenital heart disease, including cardio-obstetric management for women with CHD. Congenital Heart Compass Medical PLLC serves Rochester, NY and the Western New York region.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. The information provided here is not a substitute for individualized counseling with your cardiologist and maternal-fetal medicine specialist. Always consult with a qualified healthcare professional regarding your specific condition.